RE: Share price9 Jun 2025 09:32
Now the 1801 tox study has started, it makes perfect sense to complete the study because, if successful, it adds value. I think the next news will be for 737. It would be nice to get a couple of years cash runway, in the way of the upfront and enough to put the "one or more" CNS compounds into pre clinical. Then by the end of the year. The pipeline should be be looking very attractive.